These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 18550179)
21. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. Brini E; Ruffini F; Bergami A; Brambilla E; Dati G; Greco B; Cirillo R; Proudfoot AE; Comi G; Furlan R; Zaratin P; Martino G J Neuroimmunol; 2009 Apr; 209(1-2):33-9. PubMed ID: 19232440 [TBL] [Abstract][Full Text] [Related]
22. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. Engelhardt B J Neurol Sci; 2008 Nov; 274(1-2):23-6. PubMed ID: 18573502 [TBL] [Abstract][Full Text] [Related]
23. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Olechowski CJ; Truong JJ; Kerr BJ Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337 [TBL] [Abstract][Full Text] [Related]
24. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652 [TBL] [Abstract][Full Text] [Related]
25. Multi-faceted strategies to combat disease by interference with the chemokine system. Johnson Z; Schwarz M; Power CA; Wells TN; Proudfoot AE Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240 [TBL] [Abstract][Full Text] [Related]
26. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study. Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560 [TBL] [Abstract][Full Text] [Related]
27. Upregulation of water channel aquaporin-4 in experimental autoimmune encephalomyeritis. Miyamoto K; Nagaosa N; Motoyama M; Kataoka K; Kusunoki S J Neurol Sci; 2009 Jan; 276(1-2):103-7. PubMed ID: 18945445 [TBL] [Abstract][Full Text] [Related]
29. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803 [TBL] [Abstract][Full Text] [Related]
30. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Ransohoff RM; Liu L; Cardona AE Int Rev Neurobiol; 2007; 82():187-204. PubMed ID: 17678962 [TBL] [Abstract][Full Text] [Related]
31. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role. Martín R; Carvalho-Tavares J; Hernández M; Arnés M; Ruiz-Gutiérrez V; Nieto ML Biochem Pharmacol; 2010 Jan; 79(2):198-208. PubMed ID: 19679109 [TBL] [Abstract][Full Text] [Related]
32. Traffic of leukocytes in the central nervous system is associated with chemokine up-regulation in a severe model of herpes simplex encephalitis: an intravital microscopy study. Vilela MC; Mansur DS; Lacerda-Queiroz N; Rodrigues DH; Arantes RM; Kroon EG; Campos MA; Teixeira MM; Teixeira AL Neurosci Lett; 2008 Nov; 445(1):18-22. PubMed ID: 18782601 [TBL] [Abstract][Full Text] [Related]
33. Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model. Belmar NA; Lombardo JR; Chao DT; Li O; Ma X; Pong-Afar M; Law DA; Starling GC J Neuroimmunol; 2009 Jul; 212(1-2):65-73. PubMed ID: 19477024 [TBL] [Abstract][Full Text] [Related]
34. [A preparative method of chronic experiment autoimmune encephalomyelitis]. Yan JJ; Huang GX; Xiao B; Yang H; Wu ZG; Zhou WB Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):663-8. PubMed ID: 18772503 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic targeting of chemokine signaling in Multiple Sclerosis. Hamann I; Zipp F; Infante-Duarte C J Neurol Sci; 2008 Nov; 274(1-2):31-8. PubMed ID: 18706659 [TBL] [Abstract][Full Text] [Related]
36. Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors. Elhofy A; Kennedy KJ; Fife BT; Karpus WJ Immunol Res; 2002; 25(2):167-75. PubMed ID: 11999170 [TBL] [Abstract][Full Text] [Related]
37. Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme. 't Hart BA; Bauer J; Brok HP; Amor S J Neuroimmunol; 2005 Nov; 168(1-2):1-12. PubMed ID: 16023737 [TBL] [Abstract][Full Text] [Related]
38. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis. Uboldi C; Döring A; Alt C; Estess P; Siegelman M; Engelhardt B Eur J Immunol; 2008 Aug; 38(8):2156-67. PubMed ID: 18651702 [TBL] [Abstract][Full Text] [Related]
39. [Mouse model of experimental antoimmune encephalomyelitisin C57BL/6J and expression of macrophage migration inhibitory factor]. Gao YC; Wang YZ; Wang R; Yan JJ; Zhou WB Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):931-6. PubMed ID: 19001736 [TBL] [Abstract][Full Text] [Related]
40. An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation. Byrne FR; Winters A; Brankow D; Hu S; Juan T; Steavenson S; Doellgast G; Kuchimanchi K; Brown H; Anderson S; Smelt S; Sullivan T; Alcorn D; Tocker J; Dean C; Macmaster J; Kirchner J; Buys J; Manoukian R; Jiao E; Zou X; Campanella GS; Siu G Autoimmunity; 2009 Mar; 42(3):171-82. PubMed ID: 19301198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]